The Bird Flu is marching on and becoming an increasing threat as the H5N1 human strain is in Africa causing issues now. Producing enough vaccine fast enough just is not an option if the strain evolves of mutates to flow quickly like Influenza from human to human. One recent article in the Boston Globe accuses Rouche Pharmaceuticals of predatory price strategies for buying up all the Star Anise Fruit Crop a potential component of the TamiFlu vaccine.
Buying 2 Billion in stockpile for a Bird Flu, which may never come is a power play of which the anti-trust issues the article brings up do not address. If we do not buy some of Rouche’s products, then the EU will buy less from Boeing, Ford, GE, Wal-Mart and Microsoft. And if you look at the bigger picture we see problems all over the World as Japan attacks Intel Corp and the EU claims Boeing is being subsidized by the US Military even though the airline division is a separate division and we claim that Airbus is being subsidized, which it is by their nations to provide jobs and economic base there too.
“Lance Winslow” – Online Think Tank forum board. If you have innovative thoughts and unique perspectives, come think with Lance; http://www.WorldThinkTank.net/wttbbs/
Related Articles
No Responses to “EU, Anti Trust, Big Pharma and The Free Market Aspects of Bird Flu Vaccine”
Leave A Reply